Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 2/20 | 0.58 |
| ▸ | HRH4 | Q9H3N8 | 4/20 | 0.41 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.40 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.38 |
| ▸ | CCNK | O75909 | 2/20 | 0.38 |
| ▸ | CDK12 | Q9NYV4 | 2/20 | 0.38 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.37 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.36 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.36 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | IDH1 | O75874 | 2/20 | 0.36 |
| ▸ | IGF1R | P08069 | 1/20 | 0.35 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1088089 | 0.86 | CXCR4 (0.64) | CXCR4HRH4ROCK2EHMT2KDM4E | |
| SCHEMBL1089357 | 0.86 | CXCR4 (0.61) | CXCR4HRH4ROCK2EHMT2CCNK | |
| SCHEMBL1089515 | 0.85 | CXCR4 (0.69) | CXCR4HRH4ROCK2EHMT2MAPK10 | |
| SCHEMBL1089124 | 0.82 | CXCR4 (0.71) | CXCR4HRH4ROCK2EHMT2KDM4E | |
| SCHEMBL1089317 | 0.81 | CXCR4 (0.68) | CXCR4HRH4ROCK2EHMT2CCNK | |
| SCHEMBL1090401 | 0.81 | CXCR4 (0.67) | CXCR4HRH4ROCK2CCNKCDK12 | |
| SCHEMBL1089790 | 0.81 | CXCR4 (0.76) | CXCR4HRH4EHMT2MAPK8MAPK9 | |
| SCHEMBL1089523 | 0.81 | CXCR4 (0.66) | CXCR4HRH4ROCK2ROCK1CCNE1 | |
| SCHEMBL1089705 | 0.80 | CXCR4 (0.58) | CXCR4HRH4ROCK2EHMT2KDM4E | |
| SCHEMBL1088952 | 0.79 | CXCR4 (0.90) | CXCR4HRH4ROCK2EHMT2ROCK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120156219-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF | ONO PHARMACEUTICAL CO., LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120156219-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF | CXCR4, CXCL12, CXCR3 | CXCR4 1/4885HRH4 130/4885ROCK2 4071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.